Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Breier

Showing results (101-110 of 269) with videos related to

Pageof 27
Sort By:
Psychopharmacology|January 1, 1986
Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbineD S Charney, A Breier, P I Jatlow, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 1998
The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary reportA K Malhotra, A Breier, D Goldman, et al.
The American Journal of Psychiatry|December 1, 1996
Fluoxetine augmentation of clozapine treatment in patients with schizophreniaR W Buchanan, B Kirkpatrick, N Bryant, et al.
Lancet (London, England)|June 29, 1996
5HT 2a receptor T102C polymorphism and schizophreniaA K Malhotra, D Goldman, R Buchanan, et al.
Psychopharmacology Bulletin|January 1, 1986
Major depression and panic disorder: diagnostic and neurobiological relationshipsD S Charney, G R Heninger, L H Price, et al.
Plos One|March 12, 2015
Microbial iron mats at the Mid-Atlantic Ridge and evidence that Zetaproteobacteria may be restricted to iron-oxidizing marine systemsJarrod J Scott, John A Breier, George W Luther, et al.
Clinical Therapeutics|October 26, 2000
The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophreniaS R David, C C Taylor, B J Kinon, et al.
International Clinical Psychopharmacology|September 19, 2000
Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sampleS H Hamilton, E T Edgell, D A Revicki, et al.
Brain Research|January 8, 1999
The effects of pharmacological doses of 2-deoxyglucose on cerebral blood flow in healthy volunteersI Elman, L Sokoloff, C M Adler, et al.
The Journal of Physical Chemistry. A|February 12, 2025
Optical Spectrum and Photochemistry of Si<sub>2</sub>O<sub>2</sub><sup></sup>Taarna Studemund, Kai Pollow, Marko Förstel, et al.
Pageof 27

Showing results (101-110 of 269) with videos related to

Sort By:
Pageof 27
Psychopharmacology|January 1, 1986
Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbineD S Charney, A Breier, P I Jatlow, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 1998
The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary reportA K Malhotra, A Breier, D Goldman, et al.
The American Journal of Psychiatry|December 1, 1996
Fluoxetine augmentation of clozapine treatment in patients with schizophreniaR W Buchanan, B Kirkpatrick, N Bryant, et al.
Lancet (London, England)|June 29, 1996
5HT 2a receptor T102C polymorphism and schizophreniaA K Malhotra, D Goldman, R Buchanan, et al.
Psychopharmacology Bulletin|January 1, 1986
Major depression and panic disorder: diagnostic and neurobiological relationshipsD S Charney, G R Heninger, L H Price, et al.
Plos One|March 12, 2015
Microbial iron mats at the Mid-Atlantic Ridge and evidence that Zetaproteobacteria may be restricted to iron-oxidizing marine systemsJarrod J Scott, John A Breier, George W Luther, et al.
Clinical Therapeutics|October 26, 2000
The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophreniaS R David, C C Taylor, B J Kinon, et al.
International Clinical Psychopharmacology|September 19, 2000
Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sampleS H Hamilton, E T Edgell, D A Revicki, et al.
Brain Research|January 8, 1999
The effects of pharmacological doses of 2-deoxyglucose on cerebral blood flow in healthy volunteersI Elman, L Sokoloff, C M Adler, et al.
The Journal of Physical Chemistry. A|February 12, 2025
Optical Spectrum and Photochemistry of Si<sub>2</sub>O<sub>2</sub><sup></sup>Taarna Studemund, Kai Pollow, Marko Förstel, et al.
Pageof 27